TrialsgrambetaRCTs are beautiful

PPCOS-II

2014

Pregnancy in Polycystic Ovary Syndrome II

In 750 women with polycystic ovary syndrome and infertility, letrozole improved the cumulative live-birth rate compared with clomiphene.

Result

Efficacy: Cumulative live-birth rateRR 1.44 (95% CI 1.10-1.87) · P = 0.007

Below 1 favours clomiphene, above 1 favours letrozole.

Event rates
Absolute difference
8.4 points
NNT
12

Absolute difference and NNT are derived from the event rates.

Original publication
Subtopic
Ovulation induction in PCOS
Design
Double-blind RCT, up to 5 treatment cycles
Relevance
Important: one of several pillars.
Source
Legro RS, et al. N Engl J Med. 2014;371(2):119-129.doi 10.1056/NEJMoa1313517

Discussion & critique

Letrozole became first-line for ovulation induction in PCOS, still off-label in Germany but endorsed by reproductive-endocrinology guidance.